The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease-Reference-Cited by-同舟云学术

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

Published:2006-03-27 Issue:14 Volume:103 Page:5466-5471
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Shillingford J. M.,Murcia N. S.,Larson C. H.,Low S. H.,Hedgepeth R.,Brown N.,Flask C. A.,Novick A. C.,Goldfarb D. A.,Kramer-Zucker A.,Walz G.,Piontek K. B.,Germino G. G.,Weimbs T.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference37 articles.

1. Genetics and Pathogenesis of Polycystic Kidney Disease

2. Polycystic Kidney Disease

3. Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology

4. Molecular pathogenesis of ADPKD: The polycystin complex gets complex

Cited by 700 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deficiency of geranylgeranyl biphosphate synthase in kidney tubules causes cystic kidney disease;The FASEB Journal;2024-09

2. β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease;iScience;2024-09

3. Impaired Glucose Metabolism, Primary Cilium Defects, and Kidney Cystogenesis in Glycogen Storage Disease Type Ia;Journal of the American Society of Nephrology;2024-08-14

4. The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View;Biomedicines;2024-08-12

5. PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer;Cell Metabolism;2024-08